TREMVAC-FP

A live attenuated vaccine for the immunisation of layer pullets and breeder replacement pullets against avian encephalomyelitis (AE) and fowl pox.

FOR ANIMAL USE ONLY

TREMVAC-FP

Reg. No. G2448 (Act 36/1947)

INDICATIONS
A live attenuated vaccine for the immunisation of layer pullets and breeder replacement pullets against avian encephalomyelitis (AE) and fowl pox.

CONTENTS
Each dose of Tremvac-FP vaccine contains at least 102,5 EID50 avian encephalomyelitis virus (AE), strain Calnek 1143 and 102,0 EID50 fowl pox virus, strain Gibbs.
Contains Gentamycin as preservative.

IMMUNITY
Vaccinated chickens are protected against decreased egg production due to both diseases during lay and their progeny are protected against AE for the first few weeks of life via maternally transmitted immunity.
Full immunity will develop within 2 to 3 weeks after vaccination.
Vaccination will normally cause no visible reaction.

STORAGE

  • Store in the dark between 2 °C and 8 °C.
  • Do not freeze.
  • Avoid prolonged or repetitive exposure to high ambient temperatures.
  • Protect from exposure to direct sunlight.
  • Diluent: Store at room temperature between 20 °C and 25 °C.

WARNINGS
Withdrawal period: Do not vaccinate within 21 days of slaughter.

  • Do not vaccinate during lay or within 28 days before the beginning of the laying period.
  • Do not vaccinate chickens younger than 8 weeks of age.
  • Do not administer Tremvac-FP simultaneously with or within 14 days after vaccination with other live vaccines.
  • It is advisable to vaccinate all the susceptible chickens on the farm at the same time. If this is not feasible, strict separation of vaccinated and unvaccinated chickens should be done, to prevent the spread of the vaccine virus to the unvaccinated chickens.
  • Use according to the number of doses as indicated on the label.
  • Do not use less than 1 dose per chicken.
  • Do not mix Tremvac-FP with other vaccines.
  • Protect the reconstituted vaccine from direct sunlight.
  • Do not open and reconstitute until ready to start vaccination.
  • Use Tremvac-FP immediately after reconstitution.
  • Do not store partially used containers for future use.
  • Dispose any unused vaccine as well as all vaccine containers in accordance with waste disposal regulations.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • Vaccinate healthy chickens only.
  • Observe aseptic precautions. Ensure that all vaccination equipment (needles, syringes, etc) are clean and sterile before and during use.
  • Each vial should be used immediately after opening.
  • Avoid touching the feathers with the wing-web needle.
  • Avoid touching the bone when applying the vaccine.
  • It is good vaccination practice to avoid contact with the eyes, hands and clothing when handling the vaccine.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED
Vaccination Programme

  • The vaccine is recommended for the active immunisation of layer and breeder replacement pullets.
  • Vaccinate at the age of 8 to 16 weeks.
  • Revaccinate during the moulting period.

Dosage and administration
By the Wing-Web method.

  • The vaccine is supplied with diluent and double needle.
  • When the wing-web needle (double needle) is dipped into the reconstituted vaccine solution ensure that both grooves are filled.
  • The needle is inserted through the wing-web taking care to avoid feathered parts of the web. Avoid touching the bone when applying the vaccine.
  • Dip the wing-web needle into the reconstituted vaccine solution before every application.
  • A few chickens should be examined for vaccination success (as indicated by swelling and scab formation at the injection site) approximately 7 to 10 days after vaccination. The minor swellings and small scabs will disappear within 2 to 3 weeks.

PRESENTATION
Vial containing 1 000 doses supplied with diluent and wing-web needle packed in a cardboard box. The vials are of glass, hydrolytical class type III (Ph.Eur). Closed with halogenobutyl rubber bungs (Ph.Eur.) and sealed with coded tear-off aluminium caps which both are removed to open the vial.

REGISTRATION HOLDER                               
Intervet South Africa (Pty) Ltd.                          
20 Spartan Road                                               
Spartan, 1619, RSA                                          
Tel: +27 (0) 11 923 9300
Fax: +27 (0) 11 392 3158
www.msd-animal-health.co.za

MANUFACTURER
Intervet Inc.
Millsboro, DE 19966
USA

DATE OF PUBLICATION OF THIS PACKAGE INSERT
06 May 2015

Zimbabwe Registration number: 94/80.23.10/9367 Pharmacological classification: 802310 Vaccines Categories for distribution: V.M.G.D